Last reviewed · How we verify
Ergocalciferols
At a glance
| Generic name | Ergocalciferols |
|---|---|
| Also known as | Drisdol |
| Sponsor | Walter Reed National Military Medical Center |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Immune Mechanisms of Vitamin D to Reduce Chronic Pain After Burn (PHASE2)
- Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease (PHASE2)
- Vitamin D Homeostasis in Sarcoidosis (PHASE4)
- Vitamin D Deficiency in Adults Following a Major Burn Injury (PHASE4)
- Vitamin D Supplementation on Reported Rates of Taxane-Induced Neuropathy (PHASE2)
- A Randomised, Controlled Comparison of Vitamin D Strategies is Acute Hip Fracture Patients (PHASE4)
- Effect of Vitamin D on Skeletal Muscle Function and Qol in Patients With Chronic Intestinal Failure/Insufficiency (NA)
- Vitamin D to ENhance TraUma REcovery (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ergocalciferols CI brief — competitive landscape report
- Ergocalciferols updates RSS · CI watch RSS
- Walter Reed National Military Medical Center portfolio CI